 | • レポートコード：MRC2312MG09089 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、64ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の薬物表現型スクリーニングプラットフォーム市場規模と予測を収録しています。・世界の薬物表現型スクリーニングプラットフォーム市場：売上、2018年-2023年、2024年-2029年 ・世界の薬物表現型スクリーニングプラットフォーム市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の薬物表現型スクリーニングプラットフォーム市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「In Vivoスクリーニング」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 薬物表現型スクリーニングプラットフォームのグローバル主要企業は、Melior Discovery、 Creative Biolabs、 PerkinElmer、 TargetMol、 MIMETAS、 Evotec、 ThermoScientific、 Eurofins Discovery、 Horizon Discovery、 Crown Bioscience、 Pharmaron、 HD Biosciencesなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、薬物表現型スクリーニングプラットフォームのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の薬物表現型スクリーニングプラットフォーム市場：タイプ別、2018年-2023年、2024年-2029年 世界の薬物表現型スクリーニングプラットフォーム市場：タイプ別市場シェア、2022年 ・In Vivoスクリーニング、In Vitroスクリーニング 世界の薬物表現型スクリーニングプラットフォーム市場：用途別、2018年-2023年、2024年-2029年 世界の薬物表現型スクリーニングプラットフォーム市場：用途別市場シェア、2022年 ・製薬会社、研究機関、その他 世界の薬物表現型スクリーニングプラットフォーム市場：地域・国別、2018年-2023年、2024年-2029年 世界の薬物表現型スクリーニングプラットフォーム市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における薬物表現型スクリーニングプラットフォームのグローバル売上、2018年-2023年 ・主要企業における薬物表現型スクリーニングプラットフォームのグローバル売上シェア、2022年 ・主要企業における薬物表現型スクリーニングプラットフォームのグローバル販売量、2018年-2023年 ・主要企業における薬物表現型スクリーニングプラットフォームのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Melior Discovery、 Creative Biolabs、 PerkinElmer、 TargetMol、 MIMETAS、 Evotec、 ThermoScientific、 Eurofins Discovery、 Horizon Discovery、 Crown Bioscience、 Pharmaron、 HD Biosciences ************************************************************* ・調査・分析レポートの概要 薬物表現型スクリーニングプラットフォーム市場の定義 市場セグメント 世界の薬物表現型スクリーニングプラットフォーム市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の薬物表現型スクリーニングプラットフォーム市場規模 世界の薬物表現型スクリーニングプラットフォーム市場規模：2022年 VS 2029年 世界の薬物表現型スクリーニングプラットフォーム市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの薬物表現型スクリーニングプラットフォームの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の薬物表現型スクリーニングプラットフォーム製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：In Vivoスクリーニング、In Vitroスクリーニング 薬物表現型スクリーニングプラットフォームのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：製薬会社、研究機関、その他 薬物表現型スクリーニングプラットフォームの用途別グローバル売上・予測 ・地域別市場分析 地域別薬物表現型スクリーニングプラットフォーム市場規模 2022年と2029年 地域別薬物表現型スクリーニングプラットフォーム売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Melior Discovery、 Creative Biolabs、 PerkinElmer、 TargetMol、 MIMETAS、 Evotec、 ThermoScientific、 Eurofins Discovery、 Horizon Discovery、 Crown Bioscience、 Pharmaron、 HD Biosciences ... |
This research report provides a comprehensive analysis of the Drug Phenotypic Screening Platform market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Drug Phenotypic Screening Platform market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Drug Phenotypic Screening Platform, challenges faced by the industry, and potential opportunities for market players.
The global Drug Phenotypic Screening Platform market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Drug Phenotypic Screening Platform market presents opportunities for various stakeholders, including Pharmaceutical Company, Research Institute. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Drug Phenotypic Screening Platform market. Additionally, the growing consumer demand present avenues for market expansion.
The global Drug Phenotypic Screening Platform market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the Drug Phenotypic Screening Platform market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Drug Phenotypic Screening Platform market.
Market Overview: The report provides a comprehensive overview of the Drug Phenotypic Screening Platform market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., In Vivo Screening, In Vitro Screening), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Drug Phenotypic Screening Platform market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Drug Phenotypic Screening Platform market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Drug Phenotypic Screening Platform market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Drug Phenotypic Screening Platform market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Drug Phenotypic Screening Platform market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Drug Phenotypic Screening Platform market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Drug Phenotypic Screening Platform, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Drug Phenotypic Screening Platform market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Drug Phenotypic Screening Platform market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
In Vivo Screening
In Vitro Screening
Market segment by Application
Pharmaceutical Company
Research Institute
Others
Global Drug Phenotypic Screening Platform Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Melior Discovery
Creative Biolabs
PerkinElmer
TargetMol
MIMETAS
Evotec
ThermoScientific
Eurofins Discovery
Horizon Discovery
Crown Bioscience
Pharmaron
HD Biosciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of Drug Phenotypic Screening Platform, market overview.
Chapter 2: Global Drug Phenotypic Screening Platform market size in revenue.
Chapter 3: Detailed analysis of Drug Phenotypic Screening Platform company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Drug Phenotypic Screening Platform in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Drug Phenotypic Screening Platform Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drug Phenotypic Screening Platform Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drug Phenotypic Screening Platform Overall Market Size
2.1 Global Drug Phenotypic Screening Platform Market Size: 2022 VS 2029
2.2 Global Drug Phenotypic Screening Platform Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Drug Phenotypic Screening Platform Players in Global Market
3.2 Top Global Drug Phenotypic Screening Platform Companies Ranked by Revenue
3.3 Global Drug Phenotypic Screening Platform Revenue by Companies
3.4 Top 3 and Top 5 Drug Phenotypic Screening Platform Companies in Global Market, by Revenue in 2022
3.5 Global Companies Drug Phenotypic Screening Platform Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drug Phenotypic Screening Platform Players in Global Market
3.6.1 List of Global Tier 1 Drug Phenotypic Screening Platform Companies
3.6.2 List of Global Tier 2 and Tier 3 Drug Phenotypic Screening Platform Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Drug Phenotypic Screening Platform Market Size Markets, 2022 & 2029
4.1.2 In Vivo Screening
4.1.3 In Vitro Screening
4.2 By Type – Global Drug Phenotypic Screening Platform Revenue & Forecasts
4.2.1 By Type – Global Drug Phenotypic Screening Platform Revenue, 2018-2023
4.2.2 By Type – Global Drug Phenotypic Screening Platform Revenue, 2024-2029
4.2.3 By Type – Global Drug Phenotypic Screening Platform Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Drug Phenotypic Screening Platform Market Size, 2022 & 2029
5.1.2 Pharmaceutical Company
5.1.3 Research Institute
5.1.4 Others
5.2 By Application – Global Drug Phenotypic Screening Platform Revenue & Forecasts
5.2.1 By Application – Global Drug Phenotypic Screening Platform Revenue, 2018-2023
5.2.2 By Application – Global Drug Phenotypic Screening Platform Revenue, 2024-2029
5.2.3 By Application – Global Drug Phenotypic Screening Platform Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Drug Phenotypic Screening Platform Market Size, 2022 & 2029
6.2 By Region – Global Drug Phenotypic Screening Platform Revenue & Forecasts
6.2.1 By Region – Global Drug Phenotypic Screening Platform Revenue, 2018-2023
6.2.2 By Region – Global Drug Phenotypic Screening Platform Revenue, 2024-2029
6.2.3 By Region – Global Drug Phenotypic Screening Platform Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Drug Phenotypic Screening Platform Revenue, 2018-2029
6.3.2 US Drug Phenotypic Screening Platform Market Size, 2018-2029
6.3.3 Canada Drug Phenotypic Screening Platform Market Size, 2018-2029
6.3.4 Mexico Drug Phenotypic Screening Platform Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Drug Phenotypic Screening Platform Revenue, 2018-2029
6.4.2 Germany Drug Phenotypic Screening Platform Market Size, 2018-2029
6.4.3 France Drug Phenotypic Screening Platform Market Size, 2018-2029
6.4.4 U.K. Drug Phenotypic Screening Platform Market Size, 2018-2029
6.4.5 Italy Drug Phenotypic Screening Platform Market Size, 2018-2029
6.4.6 Russia Drug Phenotypic Screening Platform Market Size, 2018-2029
6.4.7 Nordic Countries Drug Phenotypic Screening Platform Market Size, 2018-2029
6.4.8 Benelux Drug Phenotypic Screening Platform Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Drug Phenotypic Screening Platform Revenue, 2018-2029
6.5.2 China Drug Phenotypic Screening Platform Market Size, 2018-2029
6.5.3 Japan Drug Phenotypic Screening Platform Market Size, 2018-2029
6.5.4 South Korea Drug Phenotypic Screening Platform Market Size, 2018-2029
6.5.5 Southeast Asia Drug Phenotypic Screening Platform Market Size, 2018-2029
6.5.6 India Drug Phenotypic Screening Platform Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Drug Phenotypic Screening Platform Revenue, 2018-2029
6.6.2 Brazil Drug Phenotypic Screening Platform Market Size, 2018-2029
6.6.3 Argentina Drug Phenotypic Screening Platform Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Drug Phenotypic Screening Platform Revenue, 2018-2029
6.7.2 Turkey Drug Phenotypic Screening Platform Market Size, 2018-2029
6.7.3 Israel Drug Phenotypic Screening Platform Market Size, 2018-2029
6.7.4 Saudi Arabia Drug Phenotypic Screening Platform Market Size, 2018-2029
6.7.5 UAE Drug Phenotypic Screening Platform Market Size, 2018-2029
7 Drug Phenotypic Screening Platform Companies Profiles
7.1 Melior Discovery
7.1.1 Melior Discovery Company Summary
7.1.2 Melior Discovery Business Overview
7.1.3 Melior Discovery Drug Phenotypic Screening Platform Major Product Offerings
7.1.4 Melior Discovery Drug Phenotypic Screening Platform Revenue in Global Market (2018-2023)
7.1.5 Melior Discovery Key News & Latest Developments
7.2 Creative Biolabs
7.2.1 Creative Biolabs Company Summary
7.2.2 Creative Biolabs Business Overview
7.2.3 Creative Biolabs Drug Phenotypic Screening Platform Major Product Offerings
7.2.4 Creative Biolabs Drug Phenotypic Screening Platform Revenue in Global Market (2018-2023)
7.2.5 Creative Biolabs Key News & Latest Developments
7.3 PerkinElmer
7.3.1 PerkinElmer Company Summary
7.3.2 PerkinElmer Business Overview
7.3.3 PerkinElmer Drug Phenotypic Screening Platform Major Product Offerings
7.3.4 PerkinElmer Drug Phenotypic Screening Platform Revenue in Global Market (2018-2023)
7.3.5 PerkinElmer Key News & Latest Developments
7.4 TargetMol
7.4.1 TargetMol Company Summary
7.4.2 TargetMol Business Overview
7.4.3 TargetMol Drug Phenotypic Screening Platform Major Product Offerings
7.4.4 TargetMol Drug Phenotypic Screening Platform Revenue in Global Market (2018-2023)
7.4.5 TargetMol Key News & Latest Developments
7.5 MIMETAS
7.5.1 MIMETAS Company Summary
7.5.2 MIMETAS Business Overview
7.5.3 MIMETAS Drug Phenotypic Screening Platform Major Product Offerings
7.5.4 MIMETAS Drug Phenotypic Screening Platform Revenue in Global Market (2018-2023)
7.5.5 MIMETAS Key News & Latest Developments
7.6 Evotec
7.6.1 Evotec Company Summary
7.6.2 Evotec Business Overview
7.6.3 Evotec Drug Phenotypic Screening Platform Major Product Offerings
7.6.4 Evotec Drug Phenotypic Screening Platform Revenue in Global Market (2018-2023)
7.6.5 Evotec Key News & Latest Developments
7.7 ThermoScientific
7.7.1 ThermoScientific Company Summary
7.7.2 ThermoScientific Business Overview
7.7.3 ThermoScientific Drug Phenotypic Screening Platform Major Product Offerings
7.7.4 ThermoScientific Drug Phenotypic Screening Platform Revenue in Global Market (2018-2023)
7.7.5 ThermoScientific Key News & Latest Developments
7.8 Eurofins Discovery
7.8.1 Eurofins Discovery Company Summary
7.8.2 Eurofins Discovery Business Overview
7.8.3 Eurofins Discovery Drug Phenotypic Screening Platform Major Product Offerings
7.8.4 Eurofins Discovery Drug Phenotypic Screening Platform Revenue in Global Market (2018-2023)
7.8.5 Eurofins Discovery Key News & Latest Developments
7.9 Horizon Discovery
7.9.1 Horizon Discovery Company Summary
7.9.2 Horizon Discovery Business Overview
7.9.3 Horizon Discovery Drug Phenotypic Screening Platform Major Product Offerings
7.9.4 Horizon Discovery Drug Phenotypic Screening Platform Revenue in Global Market (2018-2023)
7.9.5 Horizon Discovery Key News & Latest Developments
7.10 Crown Bioscience
7.10.1 Crown Bioscience Company Summary
7.10.2 Crown Bioscience Business Overview
7.10.3 Crown Bioscience Drug Phenotypic Screening Platform Major Product Offerings
7.10.4 Crown Bioscience Drug Phenotypic Screening Platform Revenue in Global Market (2018-2023)
7.10.5 Crown Bioscience Key News & Latest Developments
7.11 Pharmaron
7.11.1 Pharmaron Company Summary
7.11.2 Pharmaron Business Overview
7.11.3 Pharmaron Drug Phenotypic Screening Platform Major Product Offerings
7.11.4 Pharmaron Drug Phenotypic Screening Platform Revenue in Global Market (2018-2023)
7.11.5 Pharmaron Key News & Latest Developments
7.12 HD Biosciences
7.12.1 HD Biosciences Company Summary
7.12.2 HD Biosciences Business Overview
7.12.3 HD Biosciences Drug Phenotypic Screening Platform Major Product Offerings
7.12.4 HD Biosciences Drug Phenotypic Screening Platform Revenue in Global Market (2018-2023)
7.12.5 HD Biosciences Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
